BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17026517)

  • 1. Immunoreactivity of CD99 in invasive malignant melanoma.
    Wilkerson AE; Glasgow MA; Hiatt KM
    J Cutan Pathol; 2006 Oct; 33(10):663-6. PubMed ID: 17026517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA; Brill LB; Patterson JW; Wick MR
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker.
    Hartel PH; Jackson J; Ducatman BS; Zhang P
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():24-8. PubMed ID: 16972949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
    Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
    J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value.
    Monteagudo C; Calduch L; Navarro S; Joan-Figueroa A; Llombart-Bosch A
    Am J Clin Pathol; 2002 Jan; 117(1):126-31. PubMed ID: 11789717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating spitzoid melanomas from Spitz nevi through CD99 expression.
    King MS; Porchia SJ; Hiatt KM
    J Cutan Pathol; 2007 Jul; 34(7):576-80. PubMed ID: 17576338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern.
    Rajagopalan A; Browning D; Salama S
    J Cutan Pathol; 2013 Jan; 40(1):19-24. PubMed ID: 23145531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases.
    Buxton D; Bacchi CE; Gualco G; Weiss LM; Zuppan CW; Rowsell EH; Huang Q; Wang J
    Am J Clin Pathol; 2009 Apr; 131(4):574-9. PubMed ID: 19289593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIC2 detection in tumors of bone and adjacent soft tissues.
    Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
    Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma.
    Kazlouskaya V; Malhotra S; Kabigting FD; Lal K; Elston DM
    Am J Dermatopathol; 2014 May; 36(5):392-6. PubMed ID: 24247571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
    Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
    Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin.
    Nicholson SA; McDermott MB; Swanson PE; Wick MR
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):37-41. PubMed ID: 10937047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile granulosa cell tumors: immunoreactivity for CD99 and Fli-1 and EWSR1 translocation status: a study of 11 cases.
    Jarboe EA; Hirschowitz SL; Geiersbach KB; Wallander ML; Tripp SR; Layfield LJ
    Int J Gynecol Pathol; 2014 Jan; 33(1):11-5. PubMed ID: 24300529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of CD99 Paranuclear Expression in the Differential Diagnosis of Merkel Cell Carcinoma.
    Domínguez-Malagón HR; Michal M; Kazakov DV; Caro-Sánchez CH; Lino-Silva LS
    Int J Surg Pathol; 2016 Jun; 24(4):293-6. PubMed ID: 26782152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of CD163 in cutaneous spindle cell lesions.
    Pouryazdanparast P; Yu L; Cutlan JE; Olsen SH; Fullen DR; Ma L
    J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies.
    Mhawech-Fauceglia P; Herrmann F; Penetrante R; Beck A; Sait S; Block AM; Odunsi K; Fisher J; Balos L; Cheney RT
    Histopathology; 2006 Dec; 49(6):569-75. PubMed ID: 17163841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs).
    Goto A; Niki T; Terado Y; Fukushima J; Fukayama M
    Histopathology; 2004 Oct; 45(4):384-92. PubMed ID: 15469477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory neuroblastoma and other round cell lesions of the sinonasal region.
    Devaney K; Wenig BM; Abbondanzo SL
    Mod Pathol; 1996 Jun; 9(6):658-63. PubMed ID: 8782204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial primitive neuroectodermal tumor/Ewing sarcoma (PN/ES): same tumor as deep PN/ES or new entity?
    Ehrig T; Billings SD; Fanburg-Smith JC
    Ann Diagn Pathol; 2007 Jun; 11(3):153-9. PubMed ID: 17498589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A metastatic melanoma with an unusual immunophenotypic profile.
    Gao Z; Stanek A; Chen S
    Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.